A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 11.25 EUR 2.27% Market Closed
Market Cap: 95.6m EUR

Wall Street
Price Targets

APPH Price Targets Summary
Apontis Pharma AG

Wall Street analysts forecast APPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APPH is 14.62 EUR with a low forecast of 10.1 EUR and a high forecast of 17.85 EUR.

Lowest
Price Target
10.1 EUR
10% Downside
Average
Price Target
14.62 EUR
30% Upside
Highest
Price Target
17.85 EUR
59% Upside
Apontis Pharma AG Competitors:
Price Targets
AZN
AstraZeneca PLC
22% Upside
4530
Hisamitsu Pharmaceutical Co Inc
16% Upside
FAE
Faes Farma SA
6% Upside
4551
Torii Pharmaceutical Co Ltd
3% Downside
GRANULES
Granules India Ltd
32% Upside
600535
Tasly Pharmaceutical Group Co Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Apontis Pharma AG

For the last 3 years the compound annual growth rate for Apontis Pharma AG's revenue is -2%. The projected CAGR for the next 4 years is 22%.

-2%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Apontis Pharma AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Net Income
Forecast

Net Income Estimate
Apontis Pharma AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APPH's stock price target?
Price Target
14.62 EUR

According to Wall Street analysts, the average 1-year price target for APPH is 14.62 EUR with a low forecast of 10.1 EUR and a high forecast of 17.85 EUR.

What is Apontis Pharma AG's Revenue forecast?
Projected CAGR
22%

For the last 3 years the compound annual growth rate for Apontis Pharma AG's revenue is -2%. The projected CAGR for the next 4 years is 22%.

Back to Top